BioCentury
ARTICLE | Company News

Cleveland BioLabs hematology news

August 6, 2012 7:00 AM UTC

The Ministry of Industry and Trade of the Russian Federation granted Cleveland a contract worth RUB139 million ($4.3 million) to fund development of Protectan CBLB612 over about three years. The synt...